<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940721-2-00050</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Advisory Committee Meeting; Amendment of Notice</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Nonprescription Drugs Advisory Committee, which is scheduled for July 27, 1994. This meeting was announced in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  of June 24, 1994 (59 FR 32699). The amendment is being made to reflect a change in the date of the meeting from a 1-day to a 2-day meeting and to announce a closed portion of the meeting, which is scheduled for the second day and which will be held at a location different from that of the open session. The open committee discussion remains the same as originally announced. This amendment will be announced at the beginning of the open portion of the meeting. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Lee L. Zwanziger or Mae Brooks, Center for Drug Evaluation and Research (HFD&hyph;9), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4695. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> In the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  of June 24, 1994, FDA announced that a meeting of the Nonprescription Drugs Advisory Committee would be held on June 27, 1994. On page 32699, in the third column, under  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> ``Date, time, and place'' <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 --> ``Type of meeting and contact person,''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  portions of this meeting are amended, and on page 32700, in the first column, because the committee will now have a closed portion on July 28, 1994, a  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=3 -->  ``Closed committee deliberations''  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  paragraph is added to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Date, time, and place. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  July 27, 1994, 2 p.m., Parklawn Bldg., conference rms. D and E, 5600 Fishers Lane, Rockville, MD, and July 28, 1994, 8:30 a.m., Montrose Room, Ramada Inn, 1775 Rockville Pike, Rockville, MD.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Type of meeting and contact person. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Open public hearing, July 27, 1994, 2 p.m. to 3 p.m., unless public participation does not last that long; open committee discussion, 3 p.m. to 6 p.m.; closed committee deliberations, July 28, 1994, 8:30 a.m. to 12 m.; Lee L. Zwanziger or Mae Brooks, Center for Drug Evaluation and Research (HFD&hyph;9), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4695. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Closed committee deliberations. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  On July 28, 1994, the committee will discuss trade secret and/or confidential commercial information relevant to pending NDA's. This portion of the meeting will be closed to permit discussion of this information (5 U.S.C. 552b(c)(4)).  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: July 14, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 -->  Linda A. Suydam, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 -->  Interim Deputy Commissioner for Operations. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;17695 Filed 7&hyph;20&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            